Assessment of the effect of compatibility markers on bone marrow transplants in haematologic malignancies

HAEMA

Volumn 6, Issue 1, 2003, Pages 65-72

  El Shennawy, Farha ^a   Hafez, Mohammad ^a   Kamel, Hosam ^b   Salama, Osama S ^a   Al Tonbary, Yosef ^a   Mosaad, Yosef ^a   Mohsen, Sherif ^a   El Deck, Basem ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b Naser Institute Hospital   (Egypt)

Author keywords

Bone marrow transplantation; Compatibility markers; Hematologic malignancies

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA EXTRACTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HLA MATCHING; HLA TYPING; HUMAN; MALE; MIXED LYMPHOCYTE CULTURE; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SIBLING; TREATMENT OUTCOME;

EID: 0037498469     PISSN: 11082682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nademanee A, Schmidt GM, Parker P et al. The outcome of matched donor bone marrow transplantation in patients with hematological malignancies using molecular typing for donor selection and GVHD prophylaxis regimen of cyclosporine, methotrexate and prednisone. Blood 1995; 86 3: 1228-1232.
2. O'Reilly R, Papadopoulos M. Allogeneic transplantation: In Holland F, Bast R, Morton (eds): Cancer Medicine. Vol. 1, 4th edition, Williams and Wilkins, Philadelphia, 1997, pp. 1295-1324.
3. Balduini CL, Frassoni F, Noris P et al. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. Br J Haematol 2001; 114: 951-953.
4. Morishima Y, Sasazuki T, Inoko H et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206.
5. rd edition, Churchill livingstone, NY. 2000, pp. 1573-1587.
6. Min CK, kim DW, Lee JW et al. Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia. Am J Hematol 2002; 69: 15-22.
7. Elmaagacli AH, Basoglu S, Peceny R et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with chronic myeloid leukemia. Blood 2002; 15: 1130-1135.
8. nd edition, Lea & Febiger, Philadelphia, 1997, pp. 394-412.
9. Bugawan T, Apple R, Erlich H. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. Tissue Antigens 1994; 44: 137-141.
10. Bunce M, Taylor C, Welsh K. Rapid HLA-DQB typing by eight polymerase chain amplifications with sequence - specific primers. Hum Immunol 1993; 37: 201-206.
11. Kissmeyer-Nielson F, Dick HM. Lymphocyte Cytotoxicity testing. In. Histocompatibility Techniques. Dick HM, Kissmeyer-Nelson F (eds). Elsevier-North Holland, Amesterdam 1979.
12. th edition. Wiley, New york. 1997.
13. Santamaria P, Reinsmoen N, Iindstorm A et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A., B., DR) and molecularly (HLA DRBI., DQAI., DQBI) HLA identical unrelated bone marrow transplanted pairs. Blood 1994; 83: 280-287.
14. Petersodorf E, longton G, Anasetti C et al. The significance of HLA-DRBI matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
15. Maruya E, Saji H, Seki S et al. Evidence that CD31, CD49b and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 2169-2176.
16. Cukrova V, Loudova M, Sramkova I et al. Predictive value of HLA class II PCR typing for the outcome of mixed lymphocyte reaction. Folia Biol (Praha) 1998; 44: 137-141.
17. Bensinger W, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2798.
18. Schmitz N, Bacigalupo A, labopin M et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Hematol 1996; 95: 715-23.
19. Beatty P, Anasetti C, Hansen J et al. Marrow transplantation from unrelated donor for treatment of hematologic malignancies: effect of mismatching for one HLAlocus. Blood 1993; 81: 249-53.
20. Jordan F, Mc whinnie A, Turner S et al. Comparison of HLA-DRBI typing by DNA-RFLP., PCR-SSO., and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 1994; 45: 103-110.
21. Mytilineos J, Scherer S, Dunckley H et al. DNA-DR typing results of 4000 kidney transplants. Transplantation 1993; 55: 778-781.
22. Dum N, Platz P, Jakobsen B et al. HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute GVHD. Tissue Antigen 1987; 30: 213-216.
23. Varney MD, Lester S, Mc Cluskey J et al. Matching for HLA-DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999; 60: 532-538.
24. Mikelson E, longton G, Anasetti C et al. Evaluation of the mixed lymphocyte culture assay as a method for selecting unrelated donors for marrow transplant. Tissue Antigens 1996; 47: 27-36.
25. Visentainer JE, Lieber SR, Persoli LB et al. Correlation of mixed lymphocyte culture with chronic graft versus host disease following allogenic stem cell transplantation. Braz J Med Biol Res 2002; 35: 572-576.
26. Jorgensen H, Hokland P, Jensen T et al. Natural killer cells in peripheral blood after autologous bone marrow transplantation. Nat Immun 1995; 14: 164-172.
27. Sol MA, Thomsen M, Durand M et al. Flow cytometric characterization of proliferating natural killer lymphocytes from bone marrow donors in the mixed lymphocyte reaction. Cytometry 1998; 37: 67-75.
28. Nagler A, Robinowitz R, Rosengolts-Rat J et al. Natural Killer and T-cell associated surface marker expression following allogeneic and autologous bone marrow transplantation. J Hematother Stem Cell Res 2000; 9: 63-75.
29. Moretta L, Bottino C, Pende D et al. Human natural Killer cells: their origin, receptors and function. Eur J Immunol 2002; 32: 1205-1211.